In last trading session, Atara Biotherapeutics Inc (NASDAQ:ATRA) saw 72222.0 shares changing hands with its beta currently measuring 0.48. Company’s recent per share price level of $16.53 trading at -$0.32 or -1.90% at ring of the bell on the day assigns it a market valuation of $95.21M. That closing price of ATRA’s stock is at a discount of -138.96% from its 52-week high price of $39.50 and is indicating a premium of 60.68% from its 52-week low price of $6.50. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.15 million shares which gives us an average trading volume of 111.74K if we extend that period to 3-months.
For Atara Biotherapeutics Inc (ATRA), analysts’ consensus is at an average recommendation of Sell while assigning it a mean rating of 1.40. Splitting up the data highlights that, out of 1 analysts covering the stock, 1 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 0 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Atara Biotherapeutics Inc (NASDAQ:ATRA) trade information
Upright in the red during last session for losing -1.90%, in the last five days ATRA remained trading in the green while hitting it’s week-highest on Monday, 01/06/25 when the stock touched $16.53 price level, adding 11.6% to its value on the day. Atara Biotherapeutics Inc’s shares saw a change of 24.19% in year-to-date performance and have moved 24.19% in past 5-day. Atara Biotherapeutics Inc (NASDAQ:ATRA) showed a performance of 26.86% in past 30-days. Number of shares sold short was 0.64 million shares which calculate 7.11 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 14 to the stock, which implies a fall of -18.07% to its current value. Analysts have been projecting 10 as a low price target for the stock while placing it at a high target of 18. It follows that stock’s current price would jump 39.5% in reaching the projected high whereas dropping to the targeted low would mean a gain of 39.5% for stock’s current value.
Atara Biotherapeutics Inc (ATRA) estimates and forecasts
Statistics highlight that Atara Biotherapeutics Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 83.26% of value to its shares in past 6 months, showing an annual growth rate of 84.89% while that of industry is 17.00. Apart from that, the company came raising its revenue forecast for fiscal year 2025.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 13.12% during past 5 years.
Atara Biotherapeutics Inc (NASDAQ:ATRA)’s Major holders
Insiders are in possession of 22.15% of company’s total shares while institution are holding 50.82 percent of that, with stock having share float percentage of 65.29%. Investors also watch the number of corporate investors in a company very closely, which is 50.82% institutions for Atara Biotherapeutics Inc that are currently holding shares of the company. BOXER CAPITAL, LLC is the top institutional holder at ATRA for having 0.17 million shares of worth $1.41 million. And as of 2024-06-30, it was holding 0.1181 of the company’s outstanding shares.
The second largest institutional holder is LAKE STREET ADVISORS GROUP, LLC, which was holding about 11000.0 shares on 2024-06-30. The number of shares represents firm’s hold over 0.0078 of outstanding shares, having a total worth of $93500.0.
